World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
55
Citations
8917
World Ranking
3829
National Ranking
1753

Stanley A. Schwartz publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Stanley A. Schwartz sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 211 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Stanley A. Schwartz D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Stanley A. Schwartz sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 55 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Stanley A. Schwartz is affiliated with the University at Buffalo, State University of New York in the United States. Their research spans multiple fields within medicine and biochemistry, genetics, and molecular biology, with a particular focus on molecular biology, immunology, neurology, infectious diseases, and surgery.

The scientist has contributed to a variety of topics, including:

  • Galectins and Cancer Biology
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Long-Term Effects of COVID-19
  • Eosinophilic Esophagitis
  • Computational Drug Discovery Methods
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Autoimmune Bullous Skin Diseases

Stanley A. Schwartz has published extensively, with 33 contributions in medicine and 23 in biochemistry, genetics, and molecular biology. Frequently publishing in the following venues, they have 3 publications each in Microorganisms, Journal of Neuroimmune Pharmacology, and Cancers. They also have 2 publications each in Clinical Reviews in Allergy & Immunology and the American Journal of Respiratory and Critical Care Medicine.

Notable recent papers include:

  • Microbial Biofilm: A Review on Formation, Infection, Antibiotic Resistance, Control Measures, and Innovative Treatment, 2023, Microorganisms
  • Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID, 2021, Journal of Neuroimmune Pharmacology
  • Targeted Anti-IL-5 Therapies and Future Therapeutics for Hypereosinophilic Syndrome and Rare Eosinophilic Conditions, 2020, Clinical Reviews in Allergy & Immunology
  • Combination Modality Using Quercetin to Enhance the Efficacy of Docetaxel in Prostate Cancer Cells, 2023, Cancers
  • Angioedema in African American Patients Hospitalized for COVID-19, 2020, American Journal of Respiratory and Critical Care Medicine

Schwartz collaborates frequently with several co-authors, including:

  • Ravikumar Aalinkeel
  • Supriya D. Mahajan
  • Satish J. Sharma
  • Liana Bruggemann
  • Alexander Khmaladze

Best Publications

  • Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.

    L Shou;S A Schwartz;R A Good

  • The Flavonoid Quercetin Inhibits Proinflammatory Cytokine (Tumor Necrosis Factor Alpha) Gene Expression in Normal Peripheral Blood Mononuclear Cells via Modulation of the NF-κβ System

    Madhavan P. Nair;Supriya Mahajan;Jessica L. Reynolds;Ravikumar Aalinkeel

  • Amino acid sequence studies on artiodactyl fibrinopeptides: I. Dromedary camel, mule deer, and cape buffalo☆

    R.F. Doolittle;D. Schubert;S.A. Schwartz

  • Nanotechnology approach for drug addiction therapy: gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons.

    Adela C. Bonoiu;Supriya D. Mahajan;Hong Ding;Indrajit Roy

  • Inhibition of Prostate Cancer Cell Colony Formation by the Flavonoid Quercetin Correlates with Modulation of Specific Regulatory Genes

    Hari Krishnan Nair;Kesava V. K. Rao;Ravikumar Aalinkeel;Supriya Mahajan

  • Purification and Characterization of Colicin E1

    Stanley A. Schwartz;Donald R. Helinski

  • The flavonoid, quercetin, differentially regulates Th-1 (IFNγ) and Th-2 (IL4) cytokine gene expression by normal peripheral blood mononuclear cells

    Madhavan P.N Nair;Chithan Kandaswami;Supriya Mahajan;Kailash C Chadha

  • Gene Expression of Angiogenic Factors Correlates with Metastatic Potential of Prostate Cancer Cells

    Ravikumar Aalinkeel;Madhavan P. N. Nair;Gerald Sufrin;Supriya D. Mahajan

  • Reconstitution in Severe Combined Immunodeficiency by Transplantation of Marrow from an Unrelated Donor

    Richard J. O'Reilly;Richard J. O'Reilly;Bo Dupont;Bo Dupont;Savita Pahwa;Savita Pahwa;Elena Grimes;Elena Grimes

  • The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90.

    Ravikumar Aalinkeel;B. Bindukumar;Jessica L. Reynolds;Donald E. Sykes

  • Anti-HIV-1 nanotherapeutics: promises and challenges for the future

    Supriya D. Mahajan;Ravikumar Aalinkeel;Wing Cheung Law;Jessica L. Reynolds

  • Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse

    Supriya D. Mahajan;Ravikumar Aalinkeel;Donald E. Sykes;Jessica L. Reynolds

  • Immunoregulatory effects of morphine on human lymphocytes.

    M P Nair;S A Schwartz;R Polasani;J Hou

  • Morphine Regulates Gene Expression of α- and β-Chemokines and Their Receptors on Astroglial Cells Via the Opioid μ Receptor

    Supriya D. Mahajan;Stanley A. Schwartz;Thomas C. Shanahan;Ram P. Chawda

  • Biodegradable cationic polymeric nanocapsules for overcoming multidrug resistance and enabling drug–gene co-delivery to cancer cells

    Chih Kuang Chen;Wing Cheung Law;Ravikumar Aalinkeel;Yun Yu

  • Bioconjugated quantum rods as targeted probes for efficient transmigration across an in vitro blood-brain barrier.

    Gaixia Xu;Ken-Tye Yong;Indrajit Roy;Supriya D. Mahajan

  • MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier

    Adela Bonoiu;Supriya D. Mahajan;Ling Ye;Rajiv Kumar

  • Recombinant interleukin 2 therapy in severe combined immunodeficiency disease.

    R Pahwa;T Chatila;S Pahwa;C Paradise

  • Tight Junction Regulation by Morphine and HIV-1 Tat Modulates Blood–Brain Barrier Permeability

    Supriya D. Mahajan;Ravikumar Aalinkeel;Donald E. Sykes;Jessica L. Reynolds

  • Enhancing the delivery of anti retroviral drug "Saquinavir" across the blood brain barrier using nanoparticles.

    Supriya D. Mahajan;Indrajit Roy;Gai Xia Xu;Ken Tye Yong

  • Immunomodulatory effects of corticosteroids on natural killer and antibody-dependent cellular cytotoxic activities of human lymphocytes

    M P Nair;S A Schwartz

  • Natural killer cell activity in depressive illness: preliminary report.

    Ziad A. Kronfol;Madhavan P. N. Nair;JoAnn Goodson;Kavita Goel

  • Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumab.

    Mark F. Sands;Jessica W. Blume;Stanley A. Schwartz

Frequent Co-Authors

Madhavan Nair
Madhavan Nair Florida International University
Paras N. Prasad
Paras N. Prasad University at Buffalo, State University of New York
Robert A. Good
Robert A. Good University of Minnesota
Ken-Tye Yong
Ken-Tye Yong University of Sydney
Wing-Cheung Law
Wing-Cheung Law Hong Kong Polytechnic University
Indrajit Roy
Indrajit Roy University of Delhi
Gail A. Bishop
Gail A. Bishop University of Iowa
Savita Pahwa
Savita Pahwa University of Miami
Bernard J. Poiesz
Bernard J. Poiesz SUNY Upstate Medical University
Arnold S. Monto
Arnold S. Monto University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related healthcare career paths offer numerous online learning opportunities. Many students transition into nursing roles, with online accelerated nursing programs for non nurses providing a streamlined path for individuals without prior nursing experience. These programs focus on delivering essential clinical skills efficiently, making them ideal for career changers.

Accelerated nursing programs are another popular option for fast-tracking a nursing career. These programs typically build on previous education and offer intensive coursework designed to prepare students quickly for the demands of nursing practice. Applicants can find a range of options, from highly competitive to more accessible, depending on their background.

For those seeking entry-level positions, easy admission LPN programs offer a starting point in nursing with less stringent acceptance criteria. These programs prepare students for licensed practical nursing roles, providing foundational healthcare knowledge and practical skills.

Advancing beyond LPN, many pursue nurse practitioner roles through what is the easiest NP program. These programs vary in intensity and prerequisites but generally focus on developing advanced clinical competencies and leadership skills in healthcare. Exploring these online options can help tailor an educational path that aligns with both career goals and lifestyle.

Explore more about these opportunities through online accelerated nursing programs for non nurses, accelerated nursing programs, easy admission LPN programs, and what is the easiest NP program.

Best Scientists Citing Stanley A. Schwartz

Trending Scientists

Recently Published Articles